Company / Operating Margin
AVADEL PHARMACEUTICALS PLC Operating Margin History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-25.1%
FY2024
5-year range
-25.1% / 26.0%
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#68 of 136
Health Care
What the data says
At -25.1%, AVADEL PHARMACEUTICALS PLC's operating margin ranks #68 of 136 in the Health Care sector. Operating Margin has fluctuated over the past 6 years, ranging from -40.7% in FY2019 to 51.7% in FY2017.
Based on SEC 10-K filings.
-25.1% in FY2024 with a 5-year CAGR of +15.6%.
Improved from -40.7% to -25.1% over the past 5 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- +15.6pp
- 10-Year Change
- -
Sector benchmark
#68 of 136 in Health CareTop 50% of 136This company -25.1% Sector average -778.9%
▼
+96.8% above sector average
Key checks
Key Insights
- Currently 753.9pp above the Health Care sector average.
- Peak operating margin was recorded in FY2017.
- Lowest operating margin in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -25.1% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | 26.0% | +163.9% |
| FY2019 | -40.7% | - |
| FY2018 | - | - |
| FY2017 | 51.7% | +1663.4% |
| FY2016 | -3.3% | -108.1% |
| FY2015 | 40.9% | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026